By the third week post-surgery, M7's recovery entered a critical phase.
According to the pattern Eva observed in previous mouse experiments, this week should be the end of the "silent phase," where the original cells are slowly maturing after being activated. On the surface, there is no visible functional improvement, but significant changes are occurring on the tissue level. Scar formation begins, the expression of CTGF gradually increases, and FG-3019 should start to be effective this week.
But M7 isn't a mouse, its injury is more severe, its spinal structure more complex, and its recovery cycle could be entirely different.
"We might need to recalibrate the time window," Eva said at the morning meeting on the seventeenth day post-surgery. Her laptop displayed M7's daily behavior records, "Look at this indicator, the spontaneous activity frequency of M7's right leg has been slowly increasing from the tenth day post-surgery but stopped in the past three days."
